Advertisement

Topics

"Decompression Intervention of Variceal Rebleeding Trial (DIVERT)" Drugs and Medication Database

16:16 EST 16th February 2019 | BioPortfolio

Here are the most relevant "Decompression Intervention of Variceal Rebleeding Trial (DIVERT)" Drugs and Medications that we have found in our database.

More Information about "Decompression Intervention of Variceal Rebleeding Trial (DIVERT)" on BioPortfolio

We have published hundreds of Decompression Intervention of Variceal Rebleeding Trial (DIVERT) news stories on BioPortfolio along with dozens of Decompression Intervention of Variceal Rebleeding Trial (DIVERT) Clinical Trials and PubMed Articles about Decompression Intervention of Variceal Rebleeding Trial (DIVERT) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Decompression Intervention of Variceal Rebleeding Trial (DIVERT) Companies in our database. You can also find out about relevant Decompression Intervention of Variceal Rebleeding Trial (DIVERT) Drugs and Medications on this site too.

Showing "Decompression Intervention Variceal Rebleeding Trial DIVERT" Drugs and Medications, all 9

Possibly Relevant

Ethamolin [qol medical, llc.]

Ethamolin® (Ethanolamine Oleate) Injection, 5%. For Local Intravenous Use OnlyRx only

Eptifibatide [akorn, inc.]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION, safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION.EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998

Eptifibatide [auromedics pharma llc]

These highlights do not include all the information needed to use eptifibatide injection safely and effectively. See full prescribing information for eptifibatide injection. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998

Eptifibatide [aurobindo pharma limited]

These highlights do not include all the information needed to use eptifibatide injection safely and effectively. See full prescribing information for eptifibatide injection. EPTIFIBATIDE injection, for intravenous useInitial U.S. Approval: 1998

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998

Eptifibatide [sagent pharmaceuticals]

These highlights do not include all the information needed to use EPTIFIBATIDE injection safely and effectively. See full prescribing information for EPTIFIBATIDE injection. EPTIFIBATIDE injection, for intravenous useInitial U.S. Approval: 1998

Eptifibatide [teva parenteral medicines, inc.]

These highlights do not include all the information needed to use eptifibatide injection safely and effectively. See full prescribing information for eptifibatide injection. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998

Eptifibatide [mylan institutional llc]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous useInitial U.S. Approval: 1998

Teruflex blood bag system anticoagulant citrate phosphate dextrose adenine (cpda-1) [terumo corporation]

TERUFLEX BLOOD BAG SYSTEM with Diversion Blood Sampling Arm CPDA-1 SOLUTION



Advertisement
Quick Search
Advertisement
Advertisement